UK Markets close in 30 mins

IDEX Biometrics ASA (IDBA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.960.00 (0.00%)
As of 02:39PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.25
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 318.35
52-week low 34.60
50-day moving average 36.65
200-day moving average 37.51

Share statistics

Avg vol (3-month) 32.76k
Avg vol (10-day) 32.35k
Shares outstanding 515.55M
Implied shares outstanding 6N/A
Float 811.61M
% held by insiders 12.69%
% held by institutions 10.03%
Shares short (30 Jan 2023) 42.88k
Short ratio (30 Jan 2023) 40.8
Short % of float (30 Jan 2023) 4N/A
Short % of shares outstanding (30 Jan 2023) 40.02%
Shares short (prior month 29 Dec 2022) 41.81k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-877.62%

Management effectiveness

Return on assets (ttm)-104.68%
Return on equity (ttm)-219.07%

Income statement

Revenue (ttm)3.81M
Revenue per share (ttm)0.30
Quarterly revenue growth (yoy)26.80%
Gross profit (ttm)1.59M
EBITDA -32.5M
Net income avi to common (ttm)-36.71M
Diluted EPS (ttm)-2.55
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)9.06M
Total cash per share (mrq)0.67
Total debt (mrq)696k
Total debt/equity (mrq)4.67
Current ratio (mrq)4.07
Book value per share (mrq)1.50

Cash flow statement

Operating cash flow (ttm)-32.36M
Levered free cash flow (ttm)-17.84M